Carlos Graeff-Teixeira Selected Research

flubendazole

7/2003

Drug trials for treatment of human angiostrongyliasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Graeff-Teixeira Research Topics

Disease

14	Infections 03/2024 - 07/2003
11	Angiostrongyliasis 01/2022 - 07/2003
5	Schistosomiasis mansoni 12/2023 - 03/2021
3	Schistosomiasis (Bilharziasis) 12/2023 - 01/2004
3	Eosinophilia 04/2023 - 04/2009
2	Echinococcosis (Hydatid Cysts) 01/2018 - 01/2017
1	Reinfection 12/2023
1	Headache (Headaches) 04/2023
1	Asthma (Bronchial Asthma) 11/2020
1	Parasitic Diseases (Parasitic Disease) 01/2017
1	Meningoencephalitis 01/2017
1	Strongyloidiasis 01/2017
1	Toxocariasis 01/2017
1	Gnathostomiasis 01/2017
1	Meningitis 01/2016
1	Disease Progression 01/2012
1	Inflammation (Inflammations) 01/2012
1	Weight Loss (Weight Reduction) 09/2011
1	Hypersensitivity (Allergy) 06/2011
1	Bacterial Infections (Bacterial Infection) 06/2011
1	Persistent Infection 02/2008
1	Communicable Diseases (Infectious Diseases) 08/2007

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 12/2023 - 11/2010
4	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
3	Immunoglobulin G (IgG)IBA 12/2023 - 02/2008
2	AntibodiesIBA 12/2023 - 07/2003
2	Mebendazole (Anti-Worm)FDA Link 01/2007 - 03/2004
1	Immunoglobulin M (IgM)IBA 12/2023
1	EpitopesIBA 01/2022
1	PresenilinsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	MyoglobinIBA 01/2021
1	Leishmania glycoprotein gp63 (leishmanolysin)IBA 01/2021
1	CalreticulinIBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	AntithrombinsIBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	OvalbuminIBA 11/2020
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2020
1	GlycoconjugatesIBA 07/2016
1	ParaffinIBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	Recombinant ProteinsIBA 11/2012
1	Cytotoxins (Cytolysins)IBA 01/2012
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2011
1	salicylhydroxamic acid (SHAM)IBA 09/2011
1	Indicators and Reagents (Reagents)IBA 06/2011
1	SiliconesIBA 06/2011
1	Vancomycin FDA LinkGeneric 06/2011
1	EnzymesIBA 11/2010
1	ImmunosorbentsIBA 11/2010
1	Heterophile AntigensIBA 11/2010
1	Explosive Agents (Explosives)IBA 08/2007
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2007
1	PhenanthrolinesIBA 01/2007
1	isononanoyl oxybenzene sulfonate (SINOS)IBA 01/2004
1	PF 1022AIBA 07/2003
1	PyrantelIBA 07/2003
1	flubendazoleIBA 07/2003

Therapy/Procedure

1	Mass Drug Administration 05/2021
1	Drug Therapy (Chemotherapy) 05/2021
1	Microspheres (Microsphere) 01/2015
1	Prostheses and Implants (Prosthesis) 04/2009